Vir Biotechnology, Inc. (VIR) on GreekSoup https://greeksoup.ai/stocks/us/vir/ Every dated entry in the public record on Vir Biotechnology, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 Vir Biotechnology, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/vir/filings/us:VIR:filing:2026-10-08:1599bc0eb9Thu, 08 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc. filed 8-K: officer or director change, regulation fd disclosurehttps://greeksoup.ai/stocks/us/vir/filings/us:VIR:filing:2026-10-01:b47fd6d246Thu, 01 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: short interest 14,980,532 shares at the 30 September 2026 settlement, 7.01 days to coverhttps://greeksoup.ai/stocks/us/vir/short-interest/us:VIR:short-interest:2026-09-30:7e8c8fd592Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: Form 144, O'Byrne Jason plans to sell 19,357 shares worth $212,927 around 17 September 2026https://greeksoup.ai/stocks/us/vir/planned-sales/us:VIR:planned-sale:2026-09-17:85848c3585Thu, 17 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: short interest 19,660,671 shares at the 15 September 2026 settlement, 9.47 days to coverhttps://greeksoup.ai/stocks/us/vir/short-interest/us:VIR:short-interest:2026-09-15:325dc0a355Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: Form 144, O'Byrne Jason plans to sell 28,333 shares worth $315,241 around 9 September 2026https://greeksoup.ai/stocks/us/vir/planned-sales/us:VIR:planned-sale:2026-09-09:392ca0b351Wed, 09 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: short interest 21,341,508 shares at the 31 August 2026 settlement, 11.10 days to coverhttps://greeksoup.ai/stocks/us/vir/short-interest/us:VIR:short-interest:2026-08-31:680cd2f637Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: Form 144, O'Byrne Jason plans to sell 23,148 shares worth $242,591 around 25 August 2026https://greeksoup.ai/stocks/us/vir/planned-sales/us:VIR:planned-sale:2026-08-25:3f7a2f66b4Tue, 25 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: Form 144, O'Byrne Jason plans to sell 14,352 shares worth $142,124 around 24 August 2026https://greeksoup.ai/stocks/us/vir/planned-sales/us:VIR:planned-sale:2026-08-24:e430c2da0cMon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: Form 144, O'Byrne Jason plans to sell 25,000 shares worth $245,297 around 21 August 2026https://greeksoup.ai/stocks/us/vir/planned-sales/us:VIR:planned-sale:2026-08-21:2c482abbe2Fri, 21 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: short interest 19,595,909 shares at the 14 August 2026 settlement, 13.62 days to coverhttps://greeksoup.ai/stocks/us/vir/short-interest/us:VIR:short-interest:2026-08-14:cbf505d886Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: Schedule 13G filed by STATE STREET CORPORATION, 5.9% of the classhttps://greeksoup.ai/stocks/us/vir/holders/us:VIR:schedule-13:2026-08-07:cc374d8802Fri, 07 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc. Q2 FY2026 results: revenue $239 million, net income $80 millionhttps://greeksoup.ai/stocks/us/vir/results/fy2026-q2/us:VIR:result:2026-08-05:76177c9c34Wed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/vir/filings/us:VIR:filing:2026-08-05:973c38f9ecWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/vir/filings/us:VIR:filing:2026-08-05:5a294c87d0Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: Schedule 13G/A filed by Vanguard Portfolio Management, 6.8% of the classhttps://greeksoup.ai/stocks/us/vir/holders/us:VIR:schedule-13:2026-07-31:bbdb1fcf1fFri, 31 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: short interest 19,040,209 shares at the 31 July 2026 settlement, 12.24 days to coverhttps://greeksoup.ai/stocks/us/vir/short-interest/us:VIR:short-interest:2026-07-31:3f79807409Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/vir/filings/us:VIR:filing:2026-07-24:bc0186a95bFri, 24 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vir Biotechnology, Inc.: short interest 18,452,974 shares at the 15 July 2026 settlement, 11.97 days to coverhttps://greeksoup.ai/stocks/us/vir/short-interest/us:VIR:short-interest:2026-07-15:ea70ee1ceeWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>